BioMarin Pharma (BMRN) – Business Wire
-
NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
-
European Commission Approves BioMarin’s VOXZOGO® (vosoritide) for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
-
Intersect ENT Announces Appointment of New Chief Financial Officer
Back to BMRN Stock Lookup
